Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
July 18, 2024 2:15 PM 4 min read

Estee Lauder Cos Unusual Options Activity

by Benzinga Insights Benzinga Staff Writer
Follow
EL Logo
ELThe Estee Lauder Companies Inc
$99.790.32%
Overview

Deep-pocketed investors have adopted a bullish approach towards Estee Lauder Cos (NYSE:EL), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in EL usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Estee Lauder Cos. This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 55% leaning bullish and 33% bearish. Among these notable options, 2 are puts, totaling $68,580, and 7 are calls, amounting to $326,565.

Projected Price Targets

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $95.0 to $140.0 for Estee Lauder Cos over the last 3 months.

Insights into Volume & Open Interest

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Estee Lauder Cos's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Estee Lauder Cos's substantial trades, within a strike price spectrum from $95.0 to $140.0 over the preceding 30 days.

Estee Lauder Cos 30-Day Option Volume & Interest Snapshot

Noteworthy Options Activity:

About Estee Lauder Cos

Having examined the options trading patterns of Estee Lauder Cos, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Estee Lauder Cos's Current Market Status

  • Currently trading with a volume of 2,461,496, the EL's price is down by -2.4%, now at $98.26.
  • RSI readings suggest the stock is currently may be oversold.
  • Anticipated earnings release is in 29 days.

Professional Analyst Ratings for Estee Lauder Cos

In the last month, 5 experts released ratings on this stock with an average target price of $131.6.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Estee Lauder Cos with Benzinga Pro for real-time alerts.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
OptionsMarketsBZI-UOA
Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
EL CALL SWEEP BULLISH 06/20/25 $13.5 $13.4 $13.5 $105.00 $76.9K 77 2
EL CALL TRADE BEARISH 06/20/25 $19.3 $17.9 $18.2 $95.00 $69.1K 43 0
EL CALL SWEEP BULLISH 01/16/26 $18.0 $17.1 $17.69 $105.00 $61.1K 90 11
EL PUT TRADE BEARISH 01/17/25 $17.4 $17.1 $17.3 $110.00 $43.2K 2.1K 0
EL CALL TRADE NEUTRAL 09/20/24 $2.45 $2.35 $2.4 $115.00 $42.0K 853 329

Estee Lauder is a leader in the global prestige beauty market, participating across skin care (52% of 2023 sales), makeup (28%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 28% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 33% from Asia-Pacific. Estee Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

  • Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Estee Lauder Cos, targeting a price of $108.
  • An analyst from JP Morgan persists with their Overweight rating on Estee Lauder Cos, maintaining a target price of $129.
  • Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Market Perform rating on Estee Lauder Cos with a target price of $115.
  • Consistent in their evaluation, an analyst from Goldman Sachs keeps a Neutral rating on Estee Lauder Cos with a target price of $115.
  • An analyst from DA Davidson persists with their Buy rating on Estee Lauder Cos, maintaining a target price of $191.
EL Logo
ELThe Estee Lauder Companies Inc
$99.790.32%
Overview
Comments
Loading...